The substance P receptor antagonist CP-99,994 reduces acute postoperative pain

Clinical Pharmacology and Therapeutics

Volumn 64, Issue 5, 1998, Pages 562-568

  Dionne, Raymond A ^a   Max, Mitchell B ^a   Gordon, Sharon M ^a   Parada, Suzan ^a   Sang, Christine ^b   Gracely, Richard H ^a   Sethna, Navil F ^c   MacLean, David B ^a  

^a Massachusetts General Hospital ^*

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (2 METHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; IBUPROFEN; SUBSTANCE P ANTAGONIST;

ANALGESIC ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PAIN ASSESSMENT; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RECEPTOR BLOCKING; TOOTH EXTRACTION;

EID: 0031741468     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(98)90140-0     Document Type: Article

References (45)

1. Lembeck F. Zur Frage der zentralen Ubertagung afferenter Impulse. II. Mitteilung. Das Vorkommen und die Bedeutung der Substanz P. in den dorsalen Wurzeln des Ruckenmarks. Arch Exp Pathol Pharmakol 1953;219:197-213.
2. Neumann S, Doubell TP, Leslie T, Woolf CJ. Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons. Nature 1996; 384:360-4.
3. Cao YQ, Mantyh PW, Carlson EJ, Gillespie AM, Epstein CJ, Basbaum AI. Primary afferent tachykinins are required to experience moderate to intense pain. Nature 1998;392:390-4.
4. Brown JL, Liu H, Maggio JE, Vigna SR, Mantyh PW, Basbaum AI. Morphological characterization of substance P receptor-immunoreactive neurons in the rat spinal cord and trigeminal nucleus caudalis. J Comp Neurol 1995;356:327-44.
5. Liu H, Brown JL, Jasmin L, Maggio JE, Vigna SR, Mantyh PW, et al. Synaptic relationship between substance P and the substance P receptor: light and electron microsopic characterization of the mismatch between neuropeptides and their receptors. Proc Natl Acad Sci USA 1994;91:1009-13.
6. Dougherty PM, Palecek J, Paleckova V, Willis WD. Neurokinin 1 and 2 antagonists attenuate the responses and NK1 antagonists prevent the sensitization of primate spinothalamic tract neurons after intradermal capsaicin. J Neurophysiol 1994;72:1464-75.
7. Woolf CJ. Windup and central sensitization are not equivalent. Pain 1996;66:105-8.
8. Coderre TJ, Yashpal K. Intracellular messengers contributing to persistent nociception and hyperalgesia induced by L-glutamate and substance P in the rat formalin pain model. Eur J Neurosci 1994;6:1328-34.
9. Levine JD, Fields HL, Basbaum AI. Peptides and the primary afferent nociceptor. J Neurosci 1993;13:2273-86.
10. Kessler W, Kirchhoff C, Reeh PW, Handwerker HO. Excitation of cutaneous afferent nerve endings in vitro by a combination of inflammatory mediators and conditioning effect of substance P. Exp Brain Res 1992;91:467-76.
11. Hargreaves KM, Swift JQ, Roszkowski MT, Bowles W, Garry MG, Jackson DL. Pharmacology of peripheral neuropeptide and inflammatory mediator release. Oral Surg Oral Med Oral Pathol 1994;78:503-10.
12. Yashpal K, Radhakrishnan V, Coderre TJ, Henry JL. CP-96,345, but not its stereoisomer, CP-96,344, blocks the nociceptive response to intrathecally administered substance P and to noxious thermal and chemical stimuli in the rat. Neuroscience 1993;52:1039-47.
13. Seguin L, Le Marouille-Girardon S, Millan MJ. Antinociceptive profiles of non-peptidergic neurokinin-1 and neurokinin-2 receptor antagonists: a comparison to other classes of antinociceptive agent. Pain 1995;61:325-43.
14. Traub R. The spinal contribution of substance P to the generation and maintenance of inflammatory hyperalgesia in the rat. Pain 1996;67:151-61.
15. Sluka KA, Milton MA, Willis WD, Westund KN. Differential roles of neurokinin 1 and neurokinin 2 receptors in the development and maintenance of heat hyperalgesia induced by acute inflammation. Br J Pharmacol 1997; 120:1263-73.
16. 1 receptor antagonist L-733,060 in gerbils. Pain 1996;67:189-95.
17. 1 antagonist CP-99,994 on plasma extravasation in dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats. Neuropharmacology 1995;34: 255-61.
18. Lembeck F, Donnerer J, Tsuchiya M, Nagahisa A. The non-peptide tachykinin antagonist, CP-96,345, is a potent inhibitor of neurogenic inflammation. Br J Pharmacol 1992;105:527-30.
19. McLean S, Ganong A, Seymour PA, Snider RM, Desai MC, Rosen T, et al. Pharmacology of CP-99,994; a non-peptide antagonist of the tachykinin neurokinin-1 receptor. J Pharmacol Exp Ther 1993;267:472-9.
20. 1 receptor antagonist, CP-99,994, in antinociceptive tests in rat, mouse and gerbil. Eur J Pharmacol 1994;271:481-7.
21. Dionne RA, Campbell RL, Cooper SA, Hall DL, Buckingham B. Suppression of postoperative pain by pre-operative administration of ibuprofen in comparison to placebo, acetaminophen and acetaminophen plus codeine. J Clin Pharmacol 1983;23:37-43.
22. Troullos ES, Hargreaves KM, Butler DP, Dionne RA. Comparison of non-steroidal anti-inflammatory drugs, ibuprofen and flurbiprofen, to methylprednisolone and placebo for acute pain, swelling, and trismus. J Oral Maxillofac Surg 1990;48:945-52.
23. Cooper SA. New peripherally acting oral analgesic agents. Ann Rev Pharmacol Toxicol 1983;23:617-47.
24. Dionne RA, Gordon SM. Nonsteroidal anti-inflammatory drugs for acute pain control. Dent Clin North Am 1994; 38:645-67.
25. Silviotti LG, Gerber G, Rawat B, Woolf CJ. Morphine selectively depresses the slowest, NMDA-independent component of C-fibre-evoked synaptic activity in the rat spinal cord in vitro. Eur J Neurosci 1995;7:12-8.
26. Nagy I, Maggi CA, Dray A, Woolf CJ, Urban L. The role of neurokinin and N-methyl-D-aspartate receptors in synaptic transmission from capsaicin-sensitive primary afferents in the rat spinal cord in vitro. Neuroscience 1993;52:1029-37.
27. Nagy I, Miller BA, Woolf CJ. NK1 and NK2 receptors contribute to C-fibre evoked slow potentials in the spinal cord. Neuroreport 1994;5:2105-8.
28. Burnstock G. A unifying purinergic hypothesis for the initiation of pain. Lancet 1996;347:1604-5.
29. Ren K, Iadarola MJ, Dubner R. An isobolographic analysis of the effects of N-methyl-D-aspartate and NK-1 tachykinin receptor antagonists on inflammatory hyperalgesia in the rat. Br J Pharmacol 1996;117:196-202.
30. Yashpal K, Pitcher GM, Henry JL. Noxious peripheral stimulation produces antinociception mediated via substance P and opioid mechanisms in the rat tail-flick test. Brain Res 1995;674:97-103.
31. 1 neurokinin receptor activation and enhanced A- and C-fiber mediated responses in the rat spinal cord in vitro. J Neurosci 1994; 14:3672-87.
32. Abbadie C, Brown JL, Mantyh PW, Basbaum AI. Spinal cord substance P receptor immunoreactivity increases in both inflammatory and nerve injury models of persistent pain. Neuroscience 1996;70:201-9.
33. Lembeck F, Donnerer J, Colpaert FC. Increase of substance P in primary afferent nerves during chronic pain. Neuropeptides 1981;1:175-80.
34. Marlier L, Poulat P, Rajaofetra N, Privat A. Modifications of serotonin-, substance P- and calcitonin gene-related peptide-like immunoreactivities in the dorsal horn of the spinal cord of arthritic rats: a quantitative immunocytochemical study. Exp Brain Res 1991;85:482-90.
35. Woolf CJ. Phenotypic modification of primary sensory neurons: the role of nerve growth factor in the production of persistent pain. Philos Trans R Soc Lond B Biol Sci 1996;351:441-8.
36. Vaeroy H, Helle R, Forre O, Kass E, Terenius L. Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis. Pain 1988;32:21-6.
37. Russell IJ, Orr MD, Littman B, Vipraio GA, Alboukrek D, Michalek JE, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994:1593-1601.
38. Yeomans DC, Proudfit HK. Projections of substance P-immunoreactive neurons located in the ventromedial medulla to the A7 noradrenergic nucleus of the rat demonstrated using retrograde tracing combined with immunocytochemistry. Brain Res 1990;532:329-32.
39. Altier N, Stewart J. Intra-VTA infusions of the substance P analogue DiMe-C7, and intra-accumbens infusions of amphetamine induce analgesia in the formalin test for tonic pain. Brain Res 1993;628:279-85.
40. Salter MW, Henry JL. Purine-induced depression of dorsal horn neurons in the cat spinal cord: enhancement by tachykinins. Neuroscience 1987;23:903-15.
41. Smullin DH, Killing SR, Larson AA. Interactions between substance P, calcitonin gene-related peptide, taurine and excitatory amino acids in the spinal cord. Pain 1990;42:93-101.
42. Song XJ, Zhao ZQ. Interaction between substance P and excitatory amino acid receptors in modulation of nociceptive responses of cat spinal dorsal horn neurons. Neurosci Lett 1994;168:49-52.
43. Randic M, Hecimovic H, Ryu PD. Substance P modulates glutamate-induced currents in acutely isolated rat spinal dorsal horn neurones. Neurosci Lett 1990;117:74-80.
44. Nelson KA, Park KM, Robinovitz E, Tsigos C, Max MB. High-dose oral dextromethorphan in diabetic neuropathy pain and post-herpetic neuralgia: a double-blind, placebo controlled study. Neurology 1997;48:1212-8.
45. Backonja M, Arndt G, Gombar KA, Check B, Zimmermann M. Response of chronic neuropathic pain syndromes to ketamine: a preliminary study. Pain 1994;56:51-7.